Debra Zack insider trades

Open-market stock purchases and sales by Debra Zack, Chief Medical Officer at Spero Therapeutics, Inc, from SEC Form 4 filings since Mar 24, 2020.

Recent trades

DateStockTradeValue
Aug 3, 2026SPRO Spero Therapeutics, IncBought (not open market)—
Aug 3, 2026SPRO Spero Therapeutics, IncBought (not open market)—

Companies traded

  • SPRO Spero Therapeutics, Inc: other filings, last Aug 3, 2026
  • XGN Exagen Inc: other filings, last Mar 1, 2022

Get free alerts when Debra Zack files a new trade →